Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.49 USD
Change Today +0.01 / 0.18%
Volume 628.4K
MRGE On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

merge healthcare inc (MRGE) Key Developments

Merge Healthcare Incorporated Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Merge Healthcare Incorporated announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total net sales of $65,599,000 against $53,814,000 a year ago. Operating income was $9,064,000 against $5,762,000 a year ago. Income before income taxes was $4,647,000 against loss before income taxes of $3,276,000 a year ago. Net income attributable to company was $1,968,000 against net loss attributable to company of $3,973,000 a year ago. Net income available to common shareholders of the company was $905,000 against loss of $3,973,000 a year ago. Net income per diluted share was $0.01 against net loss per diluted share of $0.04 a year ago. Adjusted EBITDA was $16,668,000 or $0.09 per diluted share against $11,234,000 or $0.05 per diluted share a year ago. Adjusted net income was $10.2 million or $0.09 per diluted share against $4.4 million or $0.05 per diluted share a year ago. For the six months, the company reported total net sales of $120,002,000 against $104,717,000 a year ago. Operating income was $12,894,000 against $10,204,000 a year ago. Income before income taxes was $3,951,000 against loss before income taxes of $2,970,000 a year ago. Net income attributable to company was $19,739,000 against net loss attributable to company of $3,650,000 a year ago. Net income available to common shareholders of the company was $13,348,000 against loss of $3,650,000 a year ago. Net income per diluted share was $0.12 against net loss per diluted share of $0.04 a year ago. Net cash provided by operating activities was $8,361,000 against $14,552,000 a year ago. Purchases of property, equipment and leasehold improvements were $1,477,000 against $1,772,000 a year ago. Purchased technology and capitalized software development was $1,157,000 against $1,271,000 a year ago. Adjusted EBITDA was $27,187,000 or $0.14 per diluted share against $21,456,000 or $0.09 per diluted share a year ago.

Summa Health to Integrate Merge Healthcare Incorporated's Cardiology Solutions

Merge Healthcare Incorporated announced Summa Health will integrate Merge's cardiology solutions to support population health initiatives. The solutions will support Summa's overarching coordinated care goals, as well as provide better access to images and data to enhance workflows and reporting.

Merge Healthcare Incorporated to Report Q2, 2015 Results on Jul 23, 2015

Merge Healthcare Incorporated announced that they will report Q2, 2015 results at 8:30 AM, US Eastern Standard Time on Jul 23, 2015

Merge Healthcare Incorporated, Q2 2015 Earnings Call, Jul 23, 2015

Merge Healthcare Incorporated, Q2 2015 Earnings Call, Jul 23, 2015

Merge Healthcare Incorporated Enters into a Strategic Partnership with Toshiba America Medical Systems, Inc

Merge Healthcare Incorporated announced that it has entered into a strategic partnership with Toshiba America Medical Systems Inc. Under this new agreement, Toshiba will be able to offer its customers a full turnkey solution, combining Merge's cardiology PACS and hemodynamic monitoring solutions with the Toshiba portfolio of vascular x-ray systems. Toshiba will leverage Merge's Best in KLAS Merge Hemo, Merge's real-time documentation tool for the cardiac cath lab that facilitates the integration of cath lab documentation into the patient's electronic health record, and Merge Cardio, Merge's web-enabled enterprise-level image and information system that provides a single point of entry to the patient's complete cardio record spanning all cardiac modalities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRGE:US $5.49 USD +0.01

MRGE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DATATRAK International Inc $7.75 USD 0.00
Enzo Biochem Inc $3.00 USD 0.00
Icad Inc $3.29 USD -0.01
Luminex Corp $17.81 USD +0.38
Radview Software Ltd $0.0012 USD 0.00
View Industry Companies
 

Industry Analysis

MRGE

Industry Average

Valuation MRGE Industry Range
Price/Earnings 32.4x
Price/Sales 2.3x
Price/Book 7.5x
Price/Cash Flow 14.0x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERGE HEALTHCARE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.